• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

    304.10 +0.37 (+0.12%)
    Streaming Delayed Price Updated: 3:33 PM EST, Dec 30, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 61,525
    Open 301.27
    Bid (Size) 303.67 (160)
    Ask (Size) 304.52 (40)
    Prev. Close 303.73
    Today's Range 300.32 - 304.39
    52wk Range 211.43 - 373.69
    Shares Outstanding 22,140,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run ↗
    Amid a monster year and, more recently, a transformative deal announcement, this move raises a sharper question about how much upside is really left at today’s valuation. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues ↗
    Payoneer just posted record revenue and raised guidance, yet one fund trimmed its stake. The disconnect is where the real story is. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -6.8%
    -6.8%
    1 Month
    -5.4%
    -5.4%
    3 Month
    +12.6%
    +12.6%
    6 Month
    +26.0%
    +26.0%
    1 Year
    -6.8%
    -6.8%

    More News

    Read More
    News headline image
    Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday ↗
    Via The Motley Fool
    Topics Supply Chain
    News headline image
    Bio-Rad Reports Third-Quarter 2025 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For October 29, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For July 31, 2025 ↗
    Via Benzinga
    News headline image
    Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    News headline image
    Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad's Management to Participate in Upcoming Investor Conferences
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad (BIO) Q2 EPS Jumps 51% ↗
    Via The Motley Fool
    News headline image
    Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings ↗
    Via Benzinga
    News headline image
    Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Bio-Rad Reports Second-Quarter 2025 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    5 Analysts Have This To Say About Bio-Rad Laboratories ↗
    Via Benzinga
    News headline image
    Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    Bio-Rad Reports First-Quarter 2025 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Bio-Rad Laboratories, Inc. Class A Common Stock publicly traded?
    Yes, Bio-Rad Laboratories, Inc. Class A Common Stock is publicly traded.
    What exchange does Bio-Rad Laboratories, Inc. Class A Common Stock trade on?
    Bio-Rad Laboratories, Inc. Class A Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock?
    The ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock is BIO on the New York Stock Exchange
    What is the current price of Bio-Rad Laboratories, Inc. Class A Common Stock?
    The current price of Bio-Rad Laboratories, Inc. Class A Common Stock is 304.10
    When was Bio-Rad Laboratories, Inc. Class A Common Stock last traded?
    The last trade of Bio-Rad Laboratories, Inc. Class A Common Stock was at 12/30/25 03:33 PM ET
    What is the market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock?
    The market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock is 6.73B
    How many shares of Bio-Rad Laboratories, Inc. Class A Common Stock are outstanding?
    Bio-Rad Laboratories, Inc. Class A Common Stock has 7B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.